Premium
Suberoylanilide Hydroxamic Acid Restores Estrogen Reduced‐ cTnI Expression in Neonatal Hearts of Mice
Author(s) -
Peng Chang,
Luo Xiaomei,
Xing Qianlu,
Sun Huichao,
Huang Xupei
Publication year - 2016
Publication title -
journal of cellular biochemistry
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 165
eISSN - 1097-4644
pISSN - 0730-2312
DOI - 10.1002/jcb.25535
Subject(s) - troponin i , estrogen , chromatin immunoprecipitation , western blot , endocrinology , gene knockdown , medicine , downregulation and upregulation , histone , biology , histone deacetylase 5 , microbiology and biotechnology , chemistry , gene expression , histone deacetylase , biochemistry , apoptosis , promoter , gene , myocardial infarction
Diastolic cardiac dysfunction can be caused by abnormality in cTnI expression during cardiogenesis. In this study, we investigated the effects of estrogen on the abnormal expression of cTnI in the hearts of neonatal mice and its potential epigenetic mechanisms. We then evaluated suberoylanilide hydroxamic acid (SAHA), a HDAC inhibitor, as a new target treatment of diastolic cardiac dysfunction. Postnatal day 0.5 C57BL/6 mice were injected with estrogen for 1 week, then the hearts of 7‐day‐old neonatal mice were retrieved for examination. The activities of HDAC and HAT were assayed by colorimetry, and the interaction of cTnI with HDAC5 in mice hearts were examined using chromatin immunoprecipitation assays. The expression of cTnI was tested by quantitative real‐time RT‐PCR and Western blot. Estrogen treated groups displayed a significantly increased HDAC activity in the hearts of neonatal mice while HAT activity remained unchanged. Additionally, HDAC5 was higher at the cTnI promoter, as compared to the saline treated control groups. The acetylation of histone H3K9ac on cTnI promoter significantly decreased in the hearts of neonatal mice treated with estrogen, and the expression of cTnI at transcriptional and protein levels also decreased. SAHA was shown to increase the acetylation of histone H3K9ac and upregulate the expression of cTnI . The data demonstrated that SAHA can correct cTnI expression abnormality caused by estrogen through inhibiting the binding of HDAC5 to the promoter of cTnI . J. Cell. Biochem. 117: 2377–2384, 2016. © 2016 Wiley Periodicals, Inc.